31 results
8-K
EX-99.1
STSS
Sharps Technology Inc
31 May 24
Regulation FD Disclosure
8:35am
are currently involved in meaningful negotiations with a new customer who is a prominent American-based multinational pharma company focusing
8-K
EX-10.2
STSS
Sharps Technology Inc
24 May 24
Entry into a Material Definitive Agreement
4:15pm
; or a sublease of less than 25% of the Premises; or sublease to any affiliate of Lessee or to a vendor, customer or other entity having a business
8-K
EX-10.1
STSS
Sharps Technology Inc
24 May 24
Entry into a Material Definitive Agreement
4:15pm
, warranties, guarantees, indemnities, similar claims or other commitments to any customer or other Person with respect to the Products, which
DEF 14A
wpv8tua 4p5
7 Nov 23
Definitive proxy
8:15am
424B5
rajj4otr kpb
29 Sep 23
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
5s5ut60y7tikips
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
8-K
EX-10.2
nju86tgdosdwjod
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
S-3/A
1oe57 ywapmt
29 Aug 23
Shelf registration (amended)
4:15pm
S-3
mb5y6f7ts9 1x
22 Aug 23
Shelf registration
4:15pm
424B4
sgw w7l8sb53
25 Apr 23
Prospectus supplement with pricing info
4:15pm
10-K
22c aeps2p
31 Mar 23
Annual report
4:17pm
8-K
EX-99.1
fhx et1dd3
20 Dec 22
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company’s Innovative Syringe Products
8:20am